Unknown

Dataset Information

0

Are Dietary and Serum Advanced Glycation End Products (AGEs) Potential Contributors to Inflammation in Women with Polycystic Ovary Syndrome?

ABSTRACT:

SUBMITTER: Yurt M 

PROVIDER: S-EPMC12387888 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Advanced glycation end products (AGEs) activate mast cells.
| S-EPMC2989594 | biostudies-literature
Unknown Advanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs.
| S-EPMC4904211 | biostudies-literature
Unknown Advanced glycation end products regulate the receptor of AGEs epigenetically.
| S-EPMC9971228 | biostudies-literature
Unknown Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs.
| S-EPMC9029922 | biostudies-literature
Unknown Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular Disease.
| S-EPMC4571620 | biostudies-literature
Unknown Association Between High Dietary Advanced Glycation End Products and Periodontitis.
| S-EPMC11976597 | biostudies-literature
Unknown The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs.
| S-EPMC4038343 | biostudies-literature
Unknown Dietary Restriction of Advanced Glycation End-Products (AGEs) in Patients with Diabetes: A Systematic Review of Randomized Controlled Trials.
| S-EPMC11546279 | biostudies-literature
Unknown Hyperglycemia and advanced glycation end products (AGEs) suppress the differentiation of 3T3-L1 preadipocytes.
| S-EPMC5589639 | biostudies-literature
Unknown The role of advanced glycation end products (AGEs) and the receptor for AGEs (RAGE) in hypertrophic obstructive cardiomyopathy
| S-EPMC12289031 | biostudies-literature